Ocular Therapeutix™ Announces Closing of Public Offering of Common Stock and Full Exercise by ...

BEDFORD, Mass., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix™, Inc. (Nasdaq: OCUL) (the “Company”), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases

Related Keywords

New York ,United States ,Bedford ,Chris Brinzey ,Donald Notman ,Raymond James ,Ben Shannon ,Prospectus Department ,Ocular Therapeutix Inc ,Nasdaq ,Equity Syndicate Prospectus Department ,A Citizens Company ,Hc Wainwright Co ,Piper Sandler Co ,Exchange Commission ,Bofa Securities ,Piper Sandler ,Citizens Company ,Tryon Street ,Ocular Therapeutix ,Private Securities Litigation Reform Act ,Region ,